Cambridge Healthtech Institute’s 10th Annual

Bispecific Antibody and Combination Therapies

Engineering Multi-Specificity

January 20-21, 2021

 

Bispecific and Combination Therapies have been leading the way in the field of antibody-based therapeutics. These emerging therapies are showing exciting results through the many designs and strategies that are currently being developed to fight cancer and other diseases. CHI’s Bispecific Antibody and Combination Therapies conference will explore the engineering finesse employed in the development of these therapies, as well as the ongoing results from the clinic. Case studies highlight novel engineering approaches and platform constructs that improve safety, stability, enhanced targeting, and manufacturability.

 

Coverage will include, but is not limited to:

  • Engineering bi- and tri-specific antibodies
  • Combination therapy
  • Engineering multivalency
  • Binding
  • CARs
  • Engaging T cells
  • Bi-specific T cell Engagers (BiTEs)
  • Specificity
  • Assays
  • Target engagement
  • Specific delivery to tissues or cells
  • Case studies
  • Preclinical & clinical data
  • Stability
  • Crossing the Blood-Brain Barrier (BBB)
  • Variable domains
  • Antibody mimetics
  • Antibody-antigen binding kinetics
  • Immunogenicity
  • Effector functions
  • Conquering cancer and other diseases
  • Antitumor activity
  • Tumor-Specific Antigens (TSAs)
  • Mechanism of Action (MOA)

 

If you would like to submit a proposal to give a presentation at this meeting, please click here.

 

The deadline for priority consideration is July 24, 2020.

 

All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

 

If you are selected as a speaker for this virtual event, we request that you pre-record your presentation and be available during the “live” portion January 20-21 for interactive Q&A and panel discussions.  

 

For more details on the conference, please contact:

Mary Ruberry

Senior Conference Director

Cambridge Healthtech Institute

Phone: (+1) 781-972-5421

Email: mruberry@healthtech.com

 

For partnering and sponsorship information, please contact:

Companies A-K

Jason Gerardi

Senior Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-972-5452

Email: jgerardi@healthtech.com

 

Companies L-Z

Ashley Parsons

Business Development Manager

Cambridge Healthtech Institute

Phone: (+1) 781-972-1340

Email: ashleyparsons@healthtech.com